BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10882725)

  • 21. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression.
    Chida D; Miura O; Yoshimura A; Miyajima A
    Blood; 1999 Mar; 93(5):1567-78. PubMed ID: 10029585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
    Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
    Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2.
    Grebien F; Kerenyi MA; Kovacic B; Kolbe T; Becker V; Dolznig H; Pfeffer K; Klingmüller U; Müller M; Beug H; Müllner EW; Moriggl R
    Blood; 2008 May; 111(9):4511-22. PubMed ID: 18239084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
    Arcasoy MO; Karayal AF
    Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.
    Kirito K; Nakajima K; Watanabe T; Uchida M; Tanaka M; Ozawa K; Komatsu N
    Blood; 2002 Jan; 99(1):102-10. PubMed ID: 11756159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning and characterization of novel CIS family genes.
    Masuhara M; Sakamoto H; Matsumoto A; Suzuki R; Yasukawa H; Mitsui K; Wakioka T; Tanimura S; Sasaki A; Misawa H; Yokouchi M; Ohtsubo M; Yoshimura A
    Biochem Biophys Res Commun; 1997 Oct; 239(2):439-46. PubMed ID: 9344848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic evidence for an additional factor required for erythropoietin-induced signal transduction.
    Gaffen SL; Lai SY; Longmore GD; Liu KD; Goldsmith MA
    Blood; 1999 Jul; 94(1):74-86. PubMed ID: 10381500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
    Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
    J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical and functional interaction between p72(syk) and erythropoietin receptor.
    Duprez V; Blank U; Chrétien S; Gisselbrecht S; Mayeux P
    J Biol Chem; 1998 Dec; 273(51):33985-90. PubMed ID: 9852052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT5 as a Key Protein of Erythropoietin Signalization.
    Tóthová Z; Tomc J; Debeljak N; Solár P
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiology and function of the erythropoietin receptor.
    Yoshimura A; Misawa H
    Curr Opin Hematol; 1998 May; 5(3):171-6. PubMed ID: 9664155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis.
    Menon MP; Karur V; Bogacheva O; Bogachev O; Cuetara B; Wojchowski DM
    J Clin Invest; 2006 Mar; 116(3):683-94. PubMed ID: 16511603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proliferative signal transmission mediated by EpoR in leukemic cell lines].
    Fan H; Kanji S; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calmodulin physically interacts with the erythropoietin receptor and enhances Jak2-mediated signaling.
    Kakihana K; Yamamoto M; Iiyama M; Miura O
    Biochem Biophys Res Commun; 2005 Sep; 335(2):424-31. PubMed ID: 16084495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CIS family: negative regulators of JAK-STAT signaling.
    Yoshimura A
    Cytokine Growth Factor Rev; 1998; 9(3-4):197-204. PubMed ID: 9918119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.